These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27817251)

  • 1. Safety and efficacy of a 10% intravenous immunoglobulin preparation in patients with immune thrombocytopenic purpura: results of two international, multicenter studies.
    Kovaleva L; Apte S; Damodar S; Ramanan V; Loriya S; Navarro-Puerto J; Khojasteh A;
    Immunotherapy; 2016 Dec; 8(12):1371-1381. PubMed ID: 27817251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of intravenous immunoglobulin (Flebogamma
    Apte S; Navarro-Puerto J; Damodar S; Ramanan V; John J; Kato G; Ross C; Shah C; Torres M; Fu C'; Rucker K; Pinciaro P; Barrera G; Aragonés ME; Ayguasanosa J
    Immunotherapy; 2019 Feb; 11(2):81-89. PubMed ID: 30499734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
    Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
    Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia.
    Spadaro G; Vultaggio A; Alberto Bosi A; Reichert D; Janssen J; Lamacchia D; Nappi L; Pecoraro A; Milito C; Ferraro A; Matucci A; Bacchiarri F; Carrai V; Hibbeler A; Speckman E; Guarnieri C; Bongiovanni S; Quinti I
    Int Immunopharmacol; 2017 Mar; 44():38-42. PubMed ID: 28073042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
    Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
    Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
    Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
    Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
    Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
    Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
    Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.
    Colovic M; Dimitrijevic M; Sonnenburg C; Suvajdzic N; Donfrid M; Bogdanovic A
    Hematol J; 2003; 4(5):358-62. PubMed ID: 14502262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of Gammaplex® in idiopathic thrombocytopenic purpura (ClinicalTrials.gov--NCT00504075).
    Dash CH; Gillanders KR; Stratford Bobbitt ME; Gascoigne EW; Leach SJ
    PLoS One; 2014; 9(6):e96600. PubMed ID: 24892422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Splenectomy in adult patients with idiopathic thrombocytopenic purpura after intravenous immunoglobulin treatment].
    Nowak T; Kucharski W; Scharf R
    Acta Haematol Pol; 1994; 25(1):31-5. PubMed ID: 8209611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura.
    Aledort LM; Salama A; Kovaleva L; Robak T; Newland AC; Nugent DJ; Brenner B; Zenker O;
    Hematology; 2007 Aug; 12(4):289-95. PubMed ID: 17654054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS; Carcao M
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigam-S, a solvent/detergent-treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura.
    Newland AC; Burton I; Cavenagh JD; Copplestone A; Dolan G; Houghton J; Reilly T
    Transfus Med; 2001 Feb; 11(1):37-44. PubMed ID: 11328570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
    Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
    Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.
    Pacetti P; Garau D; Caramatti C; Mangoni L; Zamboni V; Canova N; Rizzoli V
    Curr Med Res Opin; 1997; 13(9):517-27. PubMed ID: 9169254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.